Dolby Laboratories (NYSE:DLB) major shareholder Dagmar Dolby sold 50,000 shares of Dolby Laboratories stock in a transaction dated Monday, August 7th. The stock was sold at an average price of $51.26, for a total transaction of $2,563,000.00. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Major shareholders that own 10% or more of a company’s stock are required to disclose their sales and purchases with the SEC.

Dagmar Dolby also recently made the following trade(s):

  • On Tuesday, August 8th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.
  • On Friday, August 4th, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $51.13, for a total transaction of $5,113,000.00.
  • On Wednesday, August 2nd, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $52.03, for a total transaction of $5,203,000.00.
  • On Monday, July 31st, Dagmar Dolby sold 100,000 shares of Dolby Laboratories stock. The shares were sold at an average price of $52.22, for a total transaction of $5,222,000.00.

Dolby Laboratories (DLB) traded up 0.31% during midday trading on Wednesday, reaching $51.08. 537,668 shares of the company’s stock traded hands. Dolby Laboratories has a 1-year low of $44.99 and a 1-year high of $55.02. The company has a market capitalization of $5.24 billion, a price-to-earnings ratio of 26.13 and a beta of 0.79. The firm’s 50-day moving average is $51.16 and its 200-day moving average is $50.67.

Dolby Laboratories (NYSE:DLB) last announced its quarterly earnings results on Tuesday, July 25th. The electronics maker reported $0.75 earnings per share for the quarter, beating analysts’ consensus estimates of $0.65 by $0.10. Dolby Laboratories had a net margin of 19.02% and a return on equity of 10.25%. The business had revenue of $305.67 million during the quarter, compared to analysts’ expectations of $296.88 million. During the same period last year, the business earned $0.62 earnings per share. The business’s revenue for the quarter was up 10.1% on a year-over-year basis. Analysts forecast that Dolby Laboratories will post $1.99 earnings per share for the current year.

The business also recently declared a quarterly dividend, which will be paid on Tuesday, August 15th. Shareholders of record on Monday, August 7th will be given a dividend of $0.14 per share. This represents a $0.56 dividend on an annualized basis and a dividend yield of 1.10%. The ex-dividend date of this dividend is Thursday, August 3rd. Dolby Laboratories’s dividend payout ratio is presently 28.57%.

WARNING: “Dolby Laboratories (DLB) Major Shareholder Sells $2,563,000.00 in Stock” was published by Watch List News and is owned by of Watch List News. If you are accessing this news story on another website, it was copied illegally and republished in violation of U.S. and international trademark and copyright law. The correct version of this news story can be accessed at https://www.watchlistnews.com/dolby-laboratories-dlb-major-shareholder-sells-2563000-00-in-stock/1466643.html.

Several large investors have recently made changes to their positions in DLB. Wells Fargo & Company MN boosted its stake in shares of Dolby Laboratories by 9.0% in the first quarter. Wells Fargo & Company MN now owns 554,497 shares of the electronics maker’s stock worth $29,061,000 after buying an additional 45,554 shares in the last quarter. Northeast Financial Consultants Inc bought a new stake in shares of Dolby Laboratories during the first quarter worth $229,000. Breton Hill Capital Ltd. boosted its stake in shares of Dolby Laboratories by 202.6% in the first quarter. Breton Hill Capital Ltd. now owns 16,093 shares of the electronics maker’s stock worth $843,000 after buying an additional 10,775 shares in the last quarter. Janney Montgomery Scott LLC boosted its stake in shares of Dolby Laboratories by 24.3% in the first quarter. Janney Montgomery Scott LLC now owns 21,663 shares of the electronics maker’s stock worth $1,135,000 after buying an additional 4,233 shares in the last quarter. Finally, Cardinal Capital Management boosted its stake in shares of Dolby Laboratories by 1.4% in the first quarter. Cardinal Capital Management now owns 21,093 shares of the electronics maker’s stock worth $1,105,000 after buying an additional 300 shares in the last quarter. Institutional investors and hedge funds own 50.46% of the company’s stock.

Several equities research analysts have issued reports on DLB shares. B. Riley reissued a “neutral” rating and issued a $57.00 price objective on shares of Dolby Laboratories in a research report on Sunday, April 30th. BidaskClub raised shares of Dolby Laboratories from a “sell” rating to a “hold” rating in a research report on Saturday, July 8th. Finally, Zacks Investment Research cut shares of Dolby Laboratories from a “hold” rating to a “sell” rating in a research report on Tuesday, June 27th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and two have given a buy rating to the stock. The stock presently has a consensus rating of “Hold” and a consensus price target of $54.38.

Dolby Laboratories Company Profile

Dolby Laboratories, Inc designs and manufactures audio and imaging products for the cinema, television, broadcast and entertainment industries. Its products for cinema include Digital Cinema Servers and Cinema Audio Products, and broadcast and other include Dolby Conference Phone and Other Products. It offers services to support theatrical and television production for cinema exhibition, broadcast and home entertainment, including equipment training and maintenance, mixing room alignment and equalization, as well as audio, color and light image calibration.

Insider Buying and Selling by Quarter for Dolby Laboratories (NYSE:DLB)

Receive News & Ratings for Dolby Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Dolby Laboratories and related companies with Analyst Ratings Network's FREE daily email newsletter.